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Abstract
Purpose—To study associations between surgical outcome and mean postmenstrual age (PMA)
when fibrovascular organization is detected between vascular and avascular retina following laser
for acute retinopathy of prematurity (ROP).
Methods—PMA at the time of detection of fibrovascular organization was determined in infants
who had laser treatment for stage 3 ROP. Retinal features abstracted from examination sheets
included zone, stage, and clock hours of fibrovascular organization, PMA at the times of first surgery
and diagnosis of fibrovascular organization, and outcomes (retinal attachment after one surgery and
retinal attachment at follow-up). Statistical analyses were performed to compare categorical data
(Mann-Whitney U test, t–test, Fisher exact test) and determine correlations (Spearman rank test).
Results—Fibrovascular organization was diagnosed in 38/39 eyes that required surgery and 19/41
eyes that did not. In surgical eyes, older PMA at the time of detection of fibrovascular organization,
zone II ROP, and stage 4 (versus stage 5) ROP were each associated with successful reattachment
of the retina after one surgery and at the end of follow-up. PMA at diagnosis of fibrovascular
organization was associated with zone, but not stage, of ROP when surgical intervention was
performed.
Conclusion—Fibrovascular organization between the vascular and avascular retina is important
because it is associated with the development of retinal detachment after laser for acute ROP. Further
study is required to determine if improved detection of fibrovascular organization in eyes of infants
of early PMA will improve surgical outcomes for retinal detachment.
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Untreated retinal detachment after laser treatment for acute retinopathy of prematurity (ROP)
results in poor visual outcomes in premature infants. Predicting which eyes are at the greatest
risk for retinal detachment would therefore allow early intervention and potentially improved
visual outcomes. Several groups have studied ROP after laser treatment, including the timing
of involution1 and retinal features predictive of progressive stage 4 ROP.2 These studies
emphasized the importance of monitoring the tissue between the vascular and avascular retina,
which has been clinically defined as a thickened ridge,2,3 adjacent vitreous,1 or fibrovascular
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organization.1–3 Vitreous state (the presence of haze, hemorrhage, or vitreous organization
over the optic nerve) and plus disease predicted both progressive stage 4 ROP and outcome
after surgical intervention for retinal detachment. However, the only feature that predicted
progressive retinal detachment requiring surgical intervention was clock hour extent of the
thickened ridge,2 which is referred to in this study as fibrovascular organization.
Because fibrovascular organization was already shown to be a specific and important predictive
feature, we were interested in the postmenstrual age (PMA) at diagnosis of fibrovascular
organization following laser treatment for ROP to determine possible associations with
outcome after surgery for retinal detachment. Fibrovascular organization can be better detected
on clinical examination than with wide angle digital imaging. Current technology lacks the
resolution to detect subtle fibrovascular organization and higher resolution imaging often
requires infants to be imaged under general anesthesia to assure good focus. Fibrovascular
organization can be quantified by clock hour extent and may be a practical feature to study in
a multicenter clinical trial to determine the features predictive of progressive ROP.
Patients and Methods
The sample included 41 infants who had had fibrovascular organization diagnosed after laser
for stage 3 ROP. Infants were referred for management of stages 3 to 5 ROP over the years
from 1993 through 2004.2,3 All infant eyes had had carefully recorded retinal drawings before
and after laser treatment for threshold or Type 1 prethreshold ROP4,5 by credentialed
examiners for the CRYO-ROP study.6 The retinal drawings, based on forms from the
International Classification of Retinopathy of Prematurity,7 had been developed to record
retinal features before and after treatment for Type 1 prethreshold4,5 or threshold ROP.6,8 The
ages when fibrovascular organization was detected and when surgery for retinal detachment
was performed in those eyes that showed progressive ROP were recorded as PMA in weeks
(gestational age plus chronologic age). Indications for surgery included vascularly inactive
eyes with progressive stage 4 ROP threatening the macula, dense vitreous hemorrhage, or stage
5 ROP, and these indications were consistent throughout the study period. Surgical procedures
included lens-sparing vitrectomy, scleral buckle (with later segmentation or removal), pars
plicata vitrectomy, and open sky vitrectomy. All infants were followed for 4 months after laser
to detect late progression to retinal detachment. We defined retinal attachment after the first
surgery as successful surgical reattachment of the retina 4 months after one surgery. If the
retina was detached 1 month after the first surgery, additional surgery was considered. Retinal
attachment at the end of follow-up was retinal attachment at 4 months after all surgeries,
including eyes that had fibrovascular organization, regression, and did not require surgery for
retinal detachment.
Fibrovascular organization was defined as elevated and thickened tissue at the junction of
avascular and vascular retina that had components of fibrovascular proliferation and vitreous
organization. We refer to this feature throughout this study as fibrovascular organization.
Fibrovascular organization was diagnosed at least 2 weeks following laser for acute ROP based
on a study in which retinal detachment did not develop before 2 weeks following laser.1 Eyes
included those that had not shown regression following laser as well as eyes that had apparent
recurrent thickening after treatment. Sometimes the diagnosis of fibrovascular organization
was made when neovascularization had regressed sufficiently to detect fibrovascular
organization at the junction. Fibrovascular organization was counted in clock hour extent and
was recorded separate from clock hours of neovascularization or retinal detachment (Figure
1). Because some infants were referred for management of stage 4 ROP after treatment for
laser, the time of diagnosis of fibrovascular organization may have been later than the actual
occurrence, but was within a range of 2 weeks based on review and comparison of the dates
when laser and surgery were performed for each eye.
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A database was created based on demographic data of patients (gestational age, birthweight,
sex), retinal features abstracted from examination sheets including zone, stage, and clock hours
of fibrovascular organization, PMA at the time of first surgery and at the time of diagnosis of
fibrovascular organization, and outcomes.
Human subjects’ approval for exempt status was obtained to retrospectively gather data from
patient charts. All patients received full examinations, including assessment of adequacy of
laser and the presence of skip lesions.
Statistical Analysis
Summary data are presented as means and standard deviations (SDs) or median and
interquartile range (IQR) as appropriate. Statistical analysis was performed using t-tests or
Mann-Whitney U tests. Fisher exact tests were used to compare categorical data, and
correlations were tested using the Spearman rank test. There was no adjustment for eyes in the
same infants because the study was performed to derive estimates of times of diagnosis of
fibrovascular organization in association with surgical outcome. However, the differences
between mean PMA at diagnosis of fibrovascular organization in right versus left eyes,
including the bilateral and unilateral cases, were analyzed to determine possible bias in the
sample, and none was found.
Results
This study included 80 eyes (39 pairs) from 41 infants (15 female, 26 male). The median birth-
weight was 681 g (interquartile range [IQR]: 614 –761 g) and gestational age 24 weeks (IQR:
24 –25 weeks). In all but one eye that developed vitreous hemorrhage before threshold ROP,
previous laser treatment for threshold6,8 or Type 1 prethreshold4,5 ROP was performed as
recommended. All infants had been treated with laser, and no apparent skip lesions were noted
in any eye. All eyes, except one, which developed stage 4A ROP, did so 2 or more weeks after
laser. In the one exception, the infant developed a stage 4B tractional retinal detachment within
1 week of laser.
Thirty-nine eyes developed progressive retinal detachment and required surgery, whereas 41
eyes showed regression of ROP. Because of the referral nature of the practice, the frequency
of retinal detachment is much higher than that reported in studies that report the frequency of
progression of ROP after laser.6,8 For example, some patients who received laser treatment
by outside ophthalmologists were never referred because stage 3 ROP regressed without the
development of retinal detachment, whereas other infants were specifically referred for
management of retinal detachment. Thirteen infants had bilateral surgery, 12 unilateral surgery,
and 14 had no surgery. An additional 2 infants had information only on one eye; one infant
had surgery and the other did not. The PMA at the time of the first surgery ranged from 35 to
105 weeks (Table 1).
Detection of fibrovascular organization was made in 57 infant eyes and was unknown in one.
Of the 57 eyes, 6 or more clock hours were found in 30 eyes. Fibrovascular organization was
diagnosed in 38 of 39 eyes that required surgery (information not known in one eye requiring
surgery) compared to 19 eyes that did not have surgery. Of those eyes that required surgery,
69% (27/39) had >6 clock hours of fibrovascular organization, whereas in eyes that did not
require surgery, only 3/41 eyes (7%) had 6 or more clock hours of fibrovascular organization
(Table 1).
There was no difference between right and left eyes for mean PMA at time of diagnosis of
fibrovascular organization or first surgery. The mean PMA ± SD at time of diagnosis of
fibrovascular organization was 38.4 ± 3.5 weeks (35–51 weeks; n = 24) in those eyes without
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retinal reattachment after one surgery, and 39.9 ± 2.9 weeks (35– 44 weeks; n = 14) in eyes
that had retinal attachment at 4 months after one surgery (P = NS). When the data were reviewed
(Figure 2), there was one eye in which the diagnosis of fibrovascular organization was made
at 51 weeks PMA. When this outlier was removed and the data reanalyzed, a higher mean PMA
at the time of diagnosis of fibrovascular organization was found in eyes with successful surgical
reattachment after the first surgery (39.9 ± 2.9 weeks; P = 0.017, t-test) than in eyes without
surgical attachment (37.8 ± 2.2 weeks). Significance was also found for higher mean PMA at
diagnosis of fibrovascular organization (39.7 ± 2.8 weeks; n = 42) for eyes with retinal
attachment at follow-up (including nonsurgical eyes with fibrovascular organization after
laser) than eyes that remained detached at 4-month follow up (37.7 ± 2.7 weeks; n = 14; P =
0.024, t-test; Figure 3). In the group requiring surgery, there was no significant association in
mean PMA at the time of the first surgery and surgical outcome (n = 39), including after the
outlier of 105 weeks was removed (P = NS).
When eyes were analyzed as to whether they had ≥6 clock hours of fibrovascular organization
or <6 clock hours of fibrovascular organization, there was no difference in surgical outcomes
after one or more surgeries.
When retinal attachment after the first surgery was analyzed by zone of ROP, there was a
significant association between successful surgical attachment and zone II disease (P = 0.003,
t-test). There was also a significant association between zone II ROP and retinal attachment
after all surgeries at 4 months (P < 0.0001, t-test). There were positive associations of stage of
ROP at first surgery and outcome after first surgery (RA first) (P = 0.028, Fisher exact test)
and at the end of follow-up (RA any) (P = 0.008, Fisher exact test) with retinal attachment
more likely in stage 4 than stage 5 eyes. However there was no correlation in PMA at diagnosis
of fibrovascular organization and stage 4 or 5 ROP (Spearman rank correlation P = 0.536) or
difference in median PMA at diagnosis of fibrovascular organization between stage 4 or 5 ROP
(Figure 4A). PMA at diagnosis of fibrovascular organization was correlated with zone of ROP
(Spearman rank correlation P < 0.001) with a higher PMA associated with zone II ROP (Figure
4B) (Mann-Whitney U, P < 0.0001).
Discussion
The fibrovascular organization between vascular and avascular retina is an important feature
in acute ROP. Fibrovascular organization has been shown to be an important feature in
monitoring involution or predicting progression to retinal detachment.1,2 Detection of
fibrovascular organization after adequate laser treatment predicts progressive retinal
detachment by clock hour extent (≥6 clock hours)3 and, as we have shown in this article,
outcome based on the PMA when detected. Fibrovascular organization is also quantifiable and
detectable by examination or digital imaging, making it a useful feature to monitor treatment
effects.
Our data support that the least mature infants and eyes have the poorest outcomes. In this study,
we found that eyes in which detection of fibrovascular organization after laser occurred at a
later PMA achieved successful retinal reattachment more often than did eyes in which diagnosis
of fibrovascular organization occurred earlier. Furthermore, we found a strong correlation
between zone I ROP and failed retinal reattachment following surgery. Zone and PMA at
diagnosis of fibrovascular organization were also correlated. These data support that extremely
premature infants or immature eyes, i.e., zone I with the least complete intraretinal
vascularization, respond poorly,9 including to surgical intervention. On the other hand,
although stage at first surgery did correspond to surgical outcome, it was not associated with
the PMA at diagnosis of fibrovascular organization or maturity of the eyes or infants. The
smallest eyes may have poor outcomes because they are technically more difficult to operate
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on because of their size and deformability. Persistent tunica vasculosa lentis can cause media
opacity, and engorged iris vessels may impair the ability of the iris to dilate. Both these
conditions impede visualization to the posterior segment. In addition, biologic, nontechnical
factors may play a role in progression of retinal detachment and surgical outcome.10
We had too few eyes to determine whether delay between diagnosis of fibrovascular
organization and timing of surgery affected surgical outcome. Delay of surgery may occur in
infants because of other severe medical problems or because of the need to transport an infant
to a center where pediatric vitreoretinal surgery is performed. In addition, unclear media from
extensive tunica vasculosa lentis or vitreous hemorrhage may delay the diagnosis of retinal
detachment. Vitreous hemorrhage has been reported associated with retinal detachment in 75%
of cases of infants with treated ROP in one series.1 Delay may result in more progressive
fibrovascular changes in the eye with acute ROP, including vascular activation or anterior
extension of the fibrovascular tissue to the lens. Vascular activity is associated with poor
surgical outcomes.3 Surgical intervention before the anterior extension of fibrovascular growth
with traction causing the retina to be pulled towards the lens is technically easier and is more
likely to permit the surgeon to spare the lens in vitrectomy.11–13
Fibrovascular organization between vascular and avascular retina is a unique feature in that it
is relatively easy to quantify, unlike vitreous state, and was shown to be a predictor of
progressive stage 4 ROP independent of surgical outcome.3 However it can be subtle to detect
without scleral depression and visualization in cross-section. In this study, we found that older
PMA at the time of fibrovascular organization was associated with better surgical outcomes
supporting other studies that the most premature infants and immature eyes have the most
guarded prognoses.9 However it is also possible that fibrovascular organization in eyes with
zone I ROP from infants of young PMA is difficult to detect because scleral depression and
visualization of fibrovascular organization in cross-section is difficult in posterior disease.
Prospective study of fibrovascular organization and other features may be important to
determine a window of surgical intervention in infants with stage 4 ROP or to monitor the
effect of future strategies in preventing progressive retinal detachment. The PMA at detection
of fibrovascular organization may also be helpful in choosing between surgery and future
medical therapies10,14 as they are developed. Care must be taken in interpreting these results
because they are from a small study and are retrospective.
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Wide angle image (Retcam) of right eye of premature infant demonstrating obvious
fibrovascular organization from approximately 7 to 10:30 o’clock. There is 1 clock hour of
retinal detachment posterior to fibrovascular organization from 8:30 to 9:30. (Retcam image
provided by Sharon Freedman, MD, Duke University, Durham, NC.)
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Postmenstrual age (PMA) at diagnosis of fibrovascular organization versus outcome after first
surgery for retinal detachment. Infant eyes are separated into those having successful retinal
attachment (RA) after one surgery or not.
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Postmenstrual age (PMA) at diagnosis of fibrovascular organization versus outcome at follow-
up, including surgical and regressed, nonoperated eyes. Infant eyes are separated into those
having successful retinal attachment (RA) after all surgeries or not.
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A, Box plot of postmenstrual age at diagnosis of fibrovascular organization versus retinopathy
of prematurity (ROP) stage at first surgery (P = NS). B, Box plot of postmenstrual age at
diagnosis of fibrovascular organization versus ROP zone at first surgery (P < 0.0001).
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